FDA Approves Zortress to Prevent Liver Transplant Rejection

FDA approves Zortress to prevent liver transplant rejection

Filed under: drug treatment programs maryland

The drug previously had been approved in the United States for therapy in kidney transplant recipients. According to the release, this approval … “While prevention of acute organ rejection is a key priority for physicians following liver …
Read more on Healio

Sorafenib for RCC Well-Tolerated in Older Patients

Filed under: drug treatment programs maryland

Results from a retrospective analysis indicate that the use of the antiangiogenic, VEGF inhibitor sorafenib(Drug information on sorafenib) for the treatment of advanced renal cell carcinoma was well tolerated in patients aged 65 years or older …
Read more on Cancer Network

Not your conventional nucleic acids

Filed under: drug treatment programs maryland

Last year, Mirkin and Amy S. Paller, M.D., chair of dermatology and professor of pediatrics at Feinberg, were the first to demonstrate the use of commercial moisturizers to deliver gene regulation technology for skin cancer therapy. The drug …
Read more on Eureka! Science News

Omeros Corporation's Stock Has Potential To Double This Year

Filed under: drug treatment programs maryland

NDA submission for OMS302 – OMS302, the company's lead drug candidate, is a surgical irrigation solution that aims to assist surgeons during lens replacement surgeries by maintaining pupil dilation, as well as reduce postoperative pain. Maintenance of …
Read more on Seeking Alpha

From Twitter:

#Maryland #drugtreatment advocates protest millions of dollars in cuts to state #rehab programs. http://t.co/VMHbHo5Z #mdpolitics – by IlanaKowarski (Ilana Kowarski)